Author: OurCrowd

[verse.io in EIN Presswire] Verse’s AI-powered platform recognized by G2 Crowd with seven badges for exceptional performance

SAN DIEGO, CA, USA, January 11, 2023 /EINPresswire.com/ — Verse, the cutting-edge platform that empowers businesses to connect with their customers and prospects in a more natural and personalized way, has been awarded an impressive seven badges from G2 Crowd for Winter 2023. These badges recognize Verse for its exceptional performance, ease of use, and best-in-class support in both the Small Business category and and overall. Read...

Read More

[Classiq in Calcalist] “There is a race to build the first useful quantum computer”

“Organizations are preparing for tomorrow. They develop software, run it on a relatively small scale, and when the moment comes, they will expand its use,” added Nir Minerbi, CEO of Classiq Technologies, speaking on a panel with Gil Semo, VP of development at Quantum Source, Dr. Ruti Ben Shlomi, CEO of LightSolver, and Dr. Tomer Simon, chief scientist at Microsoft Israel’s R&D center Read more...

Read More

[BlueGreen Water Technologies in EIN Presswire] The new frontier in carbon capture: Unlocking the untapped potential of oceans to fight climate change

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, January 11, 2023 /EINPresswire.com/ — BlueGreen Water Technologies (BlueGreen) has removed an estimated 3.3 million tons of carbon from the atmosphere by treating toxic algal blooms in water bodies worldwide since it started commercialization efforts in 2018. Recently, the global water-tech company has pioneered a new methodology for measuring carbon removal via water, and is deploying its technologies across multiple continents to aid the fight against climate change concurrent to its global efforts to improve water quality and availability. Read more...

Read More

[DreaMed in Business Wire] DreaMed Diabetes deploys diabetes data management and clinical decision support device into patients’ electronic medical records at Yale New Haven Health

NEW HAVEN, Conn. & TEL AVIV, Israel–(BUSINESS WIRE)–DreaMed Diabetes, a developer of AI-based diabetes care solutions, partnered with Yale New Haven Health System (YNHHS) Center for Health Care Innovation and successfully deployed DreaMed’s endo.digital clinical decision support system as a fully integrated component of Northeast Medical Group’s (NEMG) EMR workflow. Read...

Read More